Toll free

18002022232

Consultant, Pediatric Hematology-Oncology & Pediatric Bone Marrow Transplant

Dr. Amit Jain

Dr. Amit is a pediatric hematologist-oncologist with a focused interest in the diagnosis, management, and long-term care of children with both benign and malignant hematological disorders, including leukemia, lymphoma, bone marrow failure syndromes, and inherited blood disorders.

As a bone marrow transplant physician, he specializes in performing transplants for both malignant and non-malignant hematological conditions, with a particular emphasis on individualized patient care and optimizing transplant outcomes. He has undergone advanced training, completing fellowships in pediatric hematology-oncology and bone marrow transplantation at the CTC, Borivali centre, where he gained extensive experience in managing complex pediatric cases.

Over the years, he has successfully established his patient practice in Mumbai’s western suburbs, providing comprehensive outpatient, inpatient, chemotherapy, and transplant services. His academic contributions include authoring published clinical guidelines, writing chapters in medical textbooks, and publishing articles in national and international peer-reviewed journals.

He remains committed to advancing pediatric hematology-oncology and bone marrow transplantation through a combination of high-quality clinical care, academic research, and patient education.

  • MBBS: Gandhi Medical College, Bhopal, 2008
  • MD (Pediatrics): Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, 2015
  • Fellowship In Pediatric Hematology – Oncology: MCGM-Comprehensive Thalassemia Care, Pediatric Hematology Oncology and BMT Centre, Mumbai, 2018
  • Fellowship In Pediatric BMT: MCGM-Comprehensive Thalassemia Care, Pediatric Hematology Oncology and BMT Centre, Mumbai, 2022

Dr. Amit is currently a consultant in pediatric hematology-oncology and bone marrow transplantation at SunAct Cancer Institute and P. D. Hinduja Hospital & Medical Research Centre, Mumbai. Previously, he served as a consultant at the MCGM–Comprehensive Thalassemia Care, Pediatric Hematology Oncology and BMT Centre, Mumbai, following roles as Senior Registrar and Fellow in pediatric hematology-oncology at the same institute. His pediatric foundation was built during his postgraduate residency in the department of pediatrics at Lokmanya Tilak Municipal Medical College, Mumbai.

Guidelines and Chapters in the book

  1. Evidence-based Guidelines for the Diagnosis and Management of Thalassemia – Editor of guidelines
  2. Epidemiology of Thalassemia - Evidence-based Guidelines for the Diagnosis and Management of Thalassemia – Author
  3. Approach to Thrombocytopenia in Pediatrics - Critical Care Hematology - Springer


Selected Publications:

  1. Nevgi R, Gabhale Y, Jain A, Shah N, Manglani M. A study of cardiovascular abnormalities in newly diagnosed HIV infected children’. International Journal of Biomedical and Advance Research, ISSN2229-3809. Volume 9 Issue 3(2018)
  2. Sharma, R., & Jain, A. (2024). Red cell membranopathies: Case series and review of literature. Pediatric Hematology Oncology Journal.
  3. Clippings – Pediatric Hematology, Indian Pediatrics 1 Volume 61__August, 2024
  4. Srivastava S, Kanakia S, Oberoi A, Mishra A, Jain A. High-sensitivity C-Reactive Protein Levels at Presentation and its Association with Platelet Recovery in Newly Diagnosed Immune Thrombocytopenia in Children. Asian J. Pediatr. Res. [Internet]. 2025 Jan. 18 [cited 2025 Feb. 6];15(1):16-2. Available from: https://journalajpr.com/index.php/AJPR/article/view/418
  5. Suchitra Surve; Ragini Kulkarni; Yugali Kore; Amit Jain; Neha Salvi; Sanjay Bodade; Dayanand Suryawanshi; Balaji Hengane; Pradeep Dhodi; Sanjay Chauhan; Harpreet Kaur; Manisha Madkaikar; Anita Nadkarni; Identifying early Iron deficiency anemia in Sickle cell disease: Lessons learnt from newborn Sickle cell cohort in tribal district, India; Indian Practitioner, The Indian Practitioner, June 202477 (6), 11-14
  6. Pandey, Ankita & Chatterjee, Arijita & Nevgi, Reshma & Jain, Amit & Kaushik, Prakruthi & Sharma, Ratna & Manglani, Mamta. (2016). Is serum ferritin a reliable marker for evaluation of cardiac and hepatic iron overload in patients with β-thalassemia major? Pediatric Hematology Oncology Journal. 1. S21. 10.1016/j.phoj.2016.10.053.
  7. Uchil, Harshada & Jain, Amit & Jain, Abhishek & Kamat, Pranoti & Sethia, Maninder & Sharma, Ratna & Manglani, Mamta & Ghildiyal, Radha. (2017). A study of the adverse drug reactions of L-asparaginase in newly diagnosed children with acute lymphoblastic leukemia. Pediatric Hematology Oncology Journal. 2. S15-S16. 10.1016/j.phoj.2017.11.051.
  8. Jain, Amit & Agarwal, Pallavi & Fernandes, Sneha & Asangi, Santosh & T, Preetham & Ramya, H.N. & Kini, Pranoti & Sharma, Ratna & Manglani, Mamta. (2018). A Rare Immunodeficiency Disorder Masquerading As Auto-Immune Hemolytic Anemia. Pediatric Hematology Oncology Journal. 3. S33. 10.1016/j.phoj.2018.11.094.
  9. N, Ramya & Jain, Amit & Agarwal, Pallavi & Fernandes, Sneha & Misquita, Olivia & Kini, Pranoti & Sharma, Ratna & Nadkarni, Anita & Madkaikar, Manisha & Manglani, Mamta. (2018). Common Mutations of β-Thalassemia – A Changing Arena! Pediatric Hematology Oncology Journal. 3. S36. 10.1016/j.phoj.2018.11.103.
  10. Jain, Amit & Bhat, Vivekananda & Mathur, Radhika & Bulsara, Liza & Bhagat, Isha & N, Ramya & Kini, Pranoti & Patil, Rajesh & Sharma, Ratna & Manglani, Mamta. (2019). Aplastic Anaemia- Delving into The Genes. Pediatric Hematology Oncology Journal. 4. S43. 10.1016/j.phoj.2019.08.122.
  11. Amit, Jain & Ramya, H.N. & Kini, Pranoti & Patil, Rajesh & Ratna, Sharma & Manglani, Mamta. (2019). Peripheral Smear Examination: More Than Window into The Hematopoietic System. Pediatric Hematology Oncology Journal. 4. S59. 10.1016/j.phoj.2019.08.170.
  12. Amit, Jain & Ramya, H.N. & Kini, Pranoti & Patil, Rajesh & Bhagyeshree, & Sharma, Ratna & Manglani, Mamta. (2019). Pancytopenia In Infancy – A Reflection of Defective Gene (Mysm1 Deficiency: An Orphan Entity). Pediatric Hematology Oncology Journal. 4. S43. 10.1016/j.phoj.2019.08.123.
  13. To Study Renal Dysfunction In Children And Adolescents With Thalassemia Major
    Jain Amit, Ghildiyal Radha, Manglani Mamta, Gabhale Yashwant, Sharma Sujata, PawarShwetal; Pediatric Hematology Oncology Journal (2019).
  14. Rajesh Patil, H.N. Ramya, Pranoti Kini, Ratna Sharma, Santosh Khude, Amit Jain, Liza Bulsara, Mamta Manglani. Use of Sublingual Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Recipients with History of Anaphylaxis to Intravenous Cyclosporine; The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation.
  15. Jain A, Kini P, Muralidharan C, Sharma R, Manglani M; ‘Prevention of Thalassemia’, Child India, May 2021.
  16. Jain, Amit & Patil, Rajesh & Kini, Pranoti & Bapat, Kalyani & Walawalkar, Ashutosh & Das, Poulami & Mehta, Nidhi & Sharma, Ratna & Manglani, Mamta. (2021). Hematopoietic stem cell transplant (HSCT) in transfusion dependent thalassemia – Experience of a public sector hospital in Mumbai. Pediatric Hematology Oncology Journal. 6. S49.
  17. Muralidaran, C. & Patil, Rajesh & Kini, Pranoti & Jain, Amit & Walawalkar, Ashutosh & Sharma, Nistha & Srivastava, Shristi & Mehta, Nidhi & Sharma, Ratna & Dhamne, Chetan & Roy Moulik, Nirmalya & Manglani, Mamta. (2021). Haploidentical stem cell transplantation of paediatric hematolymphoid conditions - An experience from a public sector hospital. Pediatric Hematology Oncology Journal. 6. S49. 10.1016/j.phoj.2022.03.122.
  18. Jain, Amit & Patil, Rajesh & Sharma, Ratna & Kini, Pranoti & Walawalkar, Ashutosh & Das, Poulami & Srivastava, Srishti & Prince, Leo & Manglani, Mamta. (2022). Fluconazole as primary antifungal prophylaxis for pediatric hematopoietic stem cell transplant in antifungal Naive patients. Pediatric Hematology Oncology Journal. 7. S23. 10.1016/j.phoj.2022.10.062.
  19. Kulkarni, Anagha & Jain, Amit & Das, Poulami & Shah, Krisha & Walawalkar, Ashutosh & Kini, Pranoti & Sharm, Ratna & Manglani, Mamta. (2022). Inherited thrombocytopenias: Early diagnosis for optimum treatment. Pediatric Hematology Oncology Journal. 7. S8. 10.1016/j.phoj.2022.10.006.
  20. Shah, Krisha & Kini, Pranoti & Jain, Amit & Walawalkar, Ashutosh & Ganiga, Sriraksha & Mehta, Shetal & Sharma, Ratna & Manglani, Mamta. (2022). Prenatal diagnosis of thalassemia: A cost-effective step towards eradication. Pediatric Hematology Oncology Journal. 7. S9. 10.1016/j.phoj.2022.10.008.
  21. Chiwarkar, Pranoti & Patil, Rajesh & Walawalkar, Ashutosh & Jain, Amit & Kini, Pranoti & Das, Poulami & Srivastava, Srishti & Sharma, Ratna & Manglani, Mamta. (2022). Autologous hematopoietic stem cell transplant in pediatric lymphoma our experience. Pediatric Hematology Oncology Journal. 7. S23. 10.1016/j.phoj.2022.10.061.
  22. Amit Jain, Rajesh Patil, Pranoti Kini, Nidhi Mehta, Ratna Sharma, Santosh Khude, Mamta Manglani. High dose plerixafor and large volume leukapheresis – is it the answer for autologous stem cell transplants in absolute poor mobilizers? The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation.
  23. Amit Jain, Ratna Sharma, Rajesh Patil, Pranoti Kini, Santosh Khude, Mamta Manglani. Fluconazole prophylaxis for pediatric allogenic hematopoietic stem cell transplant. The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation.
  24. Amit Jain, Rajesh Patil, Arpita Gupta, Pranoti Kini, Priyanka Shelke, Ratna Sharma, Mamta Manglani, Impact of high-risk factors on the outcomes of HSCT in children with acquired severe aplastic anaemia, Pediatric Hematology Oncology Journal, Volume 9, Issue 4, Supplement, 2024, Pages S75-S76, ISSN 2468-1245, https://doi.org/10.1016/j.phoj.2024.10.119. 
  25. Suchitra Surve; Ragini Kulkarni; Yugali Kore; Amit Jain; Neha Salvi; Sanjay Bodade; Dayanand Suryawanshi; Balaji Hengane; Pradeep Dhodi; Sanjay Chauhan; Harpreet Kaur; Manisha Madkaikar; Anita Nadkarni; Identifying early Iron deficiency anemia in Sickle cell disease: Lessons learnt from newborn Sickle cell cohort in tribal district, India; Indian Practitioner, The Indian Practitioner ,June 202477 (6), 11-14
  26. Srivastava, Srishti, Swati Kanakia, Amarinder Oberoi, Arpita Mishra, and Amit Jain. 2025. “High-Sensitivity C-Reactive Protein Levels at Presentation and Its Association With Platelet Recovery in Newly Diagnosed Immune Thrombocytopenia in Children”. Asian Journal of Pediatric Research 15 (1):16-26. https://doi.org/10.9734/ajpr/2025/v15i1418.
proceed to call

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male